Literature DB >> 171318

Experimental herpes simplex virus encephalitis: Comparative effects of treatment with cytosine arabinoside and adenine arabinoside.

J F Griffith, J F Fitzwilliam, S Casagrande, S R Butler.   

Abstract

Experimental herpesvirus encephalitis in weanling mice was treated with either cytosine arabinoside or adenine arabinoside to determine the comparative effectiveness of the two compounds on survival and on the concentration of virus in the brain. The uniformly fatal course of the encephalitis was not altered by any dosage of cytosine arabinoside. In contrast, treatment with adenine arabinoside resulted in long-term survival of the majority of the infected animals. The concentration of virus measured in the brains of animals treated with two different dosages of cytosine arabinoside indicated initial suppression of viral replication with a subsequent rise to levels higher than those in the untreated controls. In the brains of adenine arabinoside-treated animals, titers of virus gradually diminished to undetectable levels by the eighth day after institution of therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171318     DOI: 10.1093/infdis/132.5.506

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.

Authors:  E R Kern; J T Richards; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

2.  Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures.

Authors:  L Pulliam; H S Panitch; J R Baringer; R D Dix
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

3.  Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.

Authors:  E de Clercq; Z X Zhang; I S Sim
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

4.  Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice.

Authors:  W M Shannon; L Westbrook; G Arnett; S Daluge; H Lee; R Vince
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

5.  Therapy of experimental herpes simplex encephalitis with aciclovir in mice.

Authors:  N H Park; D Pavan-Langston; S L McLean; D M Albert
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

6.  SAMHD1 protects cancer cells from various nucleoside-based antimetabolites.

Authors:  Nikolas Herold; Sean G Rudd; Kumar Sanjiv; Juliane Kutzner; Julia Bladh; Cynthia B J Paulin; Thomas Helleday; Jan-Inge Henter; Torsten Schaller
Journal:  Cell Cycle       Date:  2017-04-24       Impact factor: 4.534

Review 7.  Rapid and accurate viral diagnosis.

Authors:  M L Landry; D R Mayo; G D Hsiung
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.